SXI Life Sciences
7.538,73
PKT
-15,85
PKT
-0,21
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.07.06 | Novartis overweight | Prudential Financial | |
| 18.07.06 | Novartis overweight | Morgan Stanley | |
| 18.07.06 | Novartis buy | Bank Sarasin & Cie | |
| 18.07.06 | Novartis buy | Merrill Lynch | |
| 19.07.06 | Novartis overweight | Prudential Financial | |
| 19.07.06 | Novartis overweight | Lehman Brothers | |
| 21.07.06 | Novartis buy | Jyske Bank | |
| 17.07.06 | Novartis buy | Bank Sarasin & Cie | |
| 17.07.06 | Novartis kaufen | Independent Research | |
| 18.07.06 | Novartis halten | National-Bank AG | |
| 17.07.06 | Novartis buy | SEB | |
| 14.07.06 | Novartis kaufen | Fuchsbriefe | |
| 17.07.06 | Novartis overweight | Prudential Financial | |
| 13.07.06 | Novartis buy | Merrill Lynch | |
| 13.07.06 | Novartis neutral-weight | Prudential Financial | |
| 10.07.06 | Novartis kaufen | Euro am Sonntag | |
| 07.07.06 | Novartis | Weberbank | |
| 05.07.06 | Sonova kaufen | Bank Hofmann | |
| 26.06.06 | Novartis | Wirtschaftswoche | |
| 16.06.06 | Novartis buy | SEB | |
| 20.06.06 | Novartis buy | Jyske Bank | |
| 15.06.06 | Sonova | Focus Money | |
| 14.06.06 | Novartis outperform | Goldman Sachs | |
| 14.06.06 | Novartis overweight | Morgan Stanley | |
| 13.06.06 | Novartis buy | Jyske Bank | |
| 09.06.06 | Novartis kaufen | Weberbank | |
| 07.06.06 | Novartis | Jyske Bank | |
| 19.05.06 | Novartis outperform | Goldman Sachs | |
| 23.05.06 | Novartis buy | Jyske Bank | |
| 18.05.06 | Novartis buy | Merrill Lynch | |
| 17.05.06 | Novartis buy | Merrill Lynch | |
| 15.05.06 | Basilea Pharmaceutica | Global Biotech Investing | |
| 18.05.06 | Novartis buy | Jyske Bank | |
| 12.05.06 | Novartis outperform | Goldman Sachs | |
| 11.05.06 | Novartis | Zürcher Kantonalbank | |
| 11.05.06 | Novartis buy | Merrill Lynch | |
| 10.05.06 | Novartis buy | A.G. Edwards & Sons | |
| 02.05.06 | Novartis Buy | Rochdale Securities | |
| 03.05.06 | Novartis buy | Jyske Bank | |
| 26.04.06 | Novartis peer perform | Bear Stearns |